10月24日，兴森科技涨5.3%，截至发稿，报20.05元/股，成交6.20亿元，换手率2.09%，总市值340.78亿 元。 责任编辑：小浪快报 资料显示，深圳市兴森快捷电路科技股份有限公司位于广东省深圳市南山区粤海街道沙河西路与白石路 交汇处深圳湾科技生态园一区2栋A座8层，成立日期1999年3月18日，上市日期2010年6月18日，公司主 营业务涉及PCB业务、半导体业务。主营业务收入构成为：PCB印制电路板71.45%，IC封装基板 21.09%，其他4.29%，半导体测试板3.17%。 从兴森科技十大流通股东角度 数据显示，光大保德信基金旗下1只基金位居兴森科技十大流通股东。光大保德信信用添益债券A类 （360013）二季度减持1064.6万股，持有股数1129.31万股，占流通股的比例为0.75%。根据测算，今日 浮盈赚取约1140.61万元。 光大保德信信用添益债券A类（360013）成立日期2011年5月16日，最新规模41.68亿。今年以来收益 20.86%，同类排名57/6231；近一年收益28.41%，同类排名22/6005；成立以来收益188.12%。 光大保德信信用添益债券A类（36 ...

Group 1 - The core viewpoint of the news is that Baicheng Pharmaceutical (301096.SZ) reported its semi-annual results for 2025, revealing significant institutional investor activity and changes in shareholding [1] - As of August 27, 2025, a total of 10 institutional investors disclosed holdings in Baicheng Pharmaceutical A-shares, with a combined holding of 14.74 million shares, accounting for 13.50% of the total share capital [1] - The top ten institutional investors include various management partnerships and funds, with their combined holding percentage decreasing by 1.07 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, one fund, Rongtong Health Industry Flexible Allocation Mixed A/B, reported a slight decrease in holdings compared to the previous quarter [2] - Two new public funds were disclosed during this period, namely Caitong Technology Innovation Mixed A and Caitong Fusheng Mixed Initiation (LOF) A [2] - Two public funds, including Everbright Baodexin Credit Enhancement Bond Class A and Everbright Baodexin Anqi Bond Class A, were not disclosed in this period compared to the previous quarter [2]

Group 1 - The core viewpoint of the news is that Jianfan Bio (300529.SZ) reported a decrease in institutional investor holdings in its A-shares, with a total of 51.87 million shares held by six institutions, representing 6.49% of the total share capital, down by 2.00 percentage points from the previous quarter [1] Group 2 - In the public fund sector, two public funds increased their holdings, including Huabao Zhongzheng Medical ETF and Southern Zhongzheng 500 ETF, with an increase ratio of 0.25% [2] - Two public funds decreased their holdings, namely, Zhaoshang Guozhen Biomedical Index A and Yifangda Growth Enterprise ETF, with a decrease ratio of 0.11% [2] - Six public funds did not disclose their holdings in the current period, including Guangda Baodexin Credit Enhancement Bond A and others [2] Group 3 - Regarding foreign investment, the Hong Kong Central Clearing Limited is noted as an institution that did not disclose its holdings in the current period [3]